Rectangle-3-1900×571

¿Cuáles son los síntomas de la osteoartritis?

¿Le han diagnosticado recientemente

Si es así, entender sus opciones de tratamiento tal vez le ayude a pasar menos tiempo buscando alivio y más tiempo haciendo lo que le gusta.

O, si no le han diagnosticado, puede reconocer estos síntomas comunes de la OA:16

• Dolor articular
• Rigidez e hinchazón articular
• Menor rango de movimiento y flexibilidad de la articulación
• Debilidad articular
• Sensación de rechinar al mover las articulaciones
• Fatiga
• Ansiedad y depresión

Un diagnóstico temprano de la OA y un tratamiento proactivo pueden ayudarle a gestionar de forma eficaz su OA.

Más información sobre los causas y diagnóstico de la osteoartritis.

04 Symptoms_show_kid

¿Sabía que la osteoartritis puede afectar a más de una articulación?

Si tiene osteoartritis en las manos, es posible que tenga dificultades para mantener el agarre o para abrochar botones. Si es en la cadera, hombros, rodillas o tobillos, la osteoartritis puede traducirse en dificultad para caminar, ponerse de pie después de estar mucho tiempo sentado, doblarse, arrodillarse o subir escaleras.16

Summary of Indications for Use

DUROLANE (3 mL): Argentina, Australia,* Brazil, Chile, Colombia, EU,* India, New Zealand,* Russia, Switzerland,* Turkey,* United Arab Emirates: Symptomatic treatment of mild to moderate knee or hip osteoarthritis. In addition, DUROLANE has been approved in Australia, EU and New Zealand for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, shoulder, elbow, wrist, fingers, and toes.

Mexico: Symptomatic treatment of mild to moderate knee osteoarthritis.

Taiwan: Treatment of pain in OA of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. In addition, DUROLANE has been licensed for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, fingers and toes.

*DUROLANE is also indicated for pain following joint arthroscopy in the presence of osteoarthritis within 3 months of the procedure.

Full prescribing information can be found in product labeling.

Summary of risks: You should not use DUROLANE if you have infections or skin disease at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/ or stiffness at the injection site.

Full prescribing information can be found on the product labeling.

Summary of Indications for Use for Curavisc: Curavisc (2 mL): EU, Brazil, Egypt, Malaysia: Pain and disturbed function in degenerative and traumatic disease of the joints. Curavisc can be used for large joints, e.g., knee, hip, or shoulder joint. Treatment course of 3- injections, up to 5- injections.

Summary of risks: You should not use CURAVISC if you have infections or skin disease at the injection site. CURAVSIC has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/ or stiffness at the injection site.

Full prescribing information can be found on the product labeling and on the website at bioventus.com/curavisc.com.